Successful cardiac resynchronization therapy pacemaker implantation in patient with isolated persistent left superior vena cava and prominent Thebesian valve
In a Good Rhythm · 04.05.2026 · 3-4 (76-77) · 17-19
DOI: 10.5604/01.3001.0055.7734 ↗Kurz gefasst
Fachartikel in der Zeitschrift In a Good Rhythm, erschienen am 04.05.2026. Verfasst von Milena Stachyra und 3 weiteren Autor:innen.
Abstract (Originalsprache)
Heart failure (HF) is a major public health problem affecting more than 23 million patients in the world. In addition to pharmacological treatment, cardiac resynchronization therapy (CRT) is the standard of therapy for heart failure, according to the current guidelines. Persistent left superior vena cava (PLSVC), although typically asymptomatic, can complicate lead delivery to the right and left ventricles. We present an 83-year-old man with paroxysmal high-degree atrioventricular block, chronic heart failure with reduced ejection fraction and intermittent left bundle branch block, who was eligible for CRT implantation. Pre-procedural left-sided venogram confirmed the presence of PLSVC with absent right superior vena cava (isolated PLSVC), and prominent Thebesian valve prevented exiting the CS with a conventional stylet-driven lead. A long guidewire and an Attain Command™ guiding catheter were used to cross the valve. Due to an acute CS/RV angle, a deep septal position for CSP was unattainable. The ventricular lead was fixed in an alpha-loop configuration. Crossing the tricuspid valve and positioned at the mid-ventricular septum with optimal electrical parameters. With the Thebesian valve now open, an atrial lead was placed in the right atrial appendage without complications. For LV lead implantation, an Attain Command™ + SureValve guiding catheter (Medtronic) was advanced over the wire into the CS. An S-shaped passive fixation electrode (Sentus ProMRI L-85, Biotronik) was placed using an over-the-wire technique, achieving acceptable electrical parameters. At the one-month follow-up, we confirmed correct electrical parameters and 99% biventricular stimulation. Device implantation and optimization of heart failure pharmacotherapy improved the patient’s status from NYHA class III to NYHA class I. According to the literature and our own experience, CRT implantation in patients with isolated PLSVC and a prominent coronary sinus valve requires minor technical modification, but it is a feasible and safe procedure.
Zitieren
APA
Stachyra, M., Chromiński, T., Krawiec, K., & Błaszczak, P. (2026). Successful cardiac resynchronization therapy pacemaker implantation in patient with isolated persistent left superior vena cava and prominent Thebesian valve. In a Good Rhythm, 3-4(76-77), 17-19. https://doi.org/10.5604/01.3001.0055.7734
Vancouver
Stachyra M, Chromiński T, Krawiec K, Błaszczak P. Successful cardiac resynchronization therapy pacemaker implantation in patient with isolated persistent left superior vena cava and prominent Thebesian valve. In a Good Rhythm. 2026;3-4(76-77):17-19. doi:10.5604/01.3001.0055.7734
BibTeX
@article{Stachyra2026,
author = {Stachyra, Milena and Chromiński, Tomasz and Krawiec, Karol and Błaszczak, Piotr},
title = {Successful cardiac resynchronization therapy pacemaker implantation in patient with isolated persistent left superior vena cava and prominent Thebesian valve},
journal = {In a Good Rhythm},
year = {2026},
volume = {3-4},
number = {76-77},
pages = {17--19},
doi = {10.5604/01.3001.0055.7734}
}
EUVIMED